Keyphrases
Nonmyeloablative
100%
Adoptive Cell Therapy
100%
Preconditioning Regimen
100%
Adverse Events
50%
Clinical Response
50%
Total Body Irradiation
50%
Absolute Lymphocyte Count
50%
Cell Infusion
50%
Serum Levels
33%
Neutropenia
33%
Thrombocytopenia
33%
Cyclophosphamide
33%
Tumor-infiltrating Lymphocytes
33%
Fludarabine
33%
Bone Marrow Suppression
33%
Cumulative Dose
16%
Bone Marrow
16%
T Cells
16%
Lymphopenia
16%
Acute Lymphoblastic Leukemia
16%
Length of Hospital Stay
16%
Platelet Count
16%
Genetic Engineering
16%
Overall Survival
16%
Patient with Tumor
16%
Absolute Neutrophil Count
16%
Patients with Cancer
16%
Metastatic Melanoma
16%
Chimeric Antigen Receptor T Cells (CAR-T)
16%
Receiver Operating Characteristic Analysis
16%
Cardiotoxicity
16%
Maximal Effect
16%
Inflammatory Index
16%
Neutrophil-to-lymphocyte Ratio
16%
Platelet-to-lymphocyte Ratio
16%
Response Event
16%
Febrile Neutropenia
16%
Myeloablative Regimen
16%
Myeloablative Therapy
16%
Bone Marrow Recovery
16%
Objective Tumor Response
16%
Medicine and Dentistry
Cell Therapy
100%
Lymphocyte
100%
T Cell
100%
Infusion
60%
Neoplasm
60%
Adverse Event
60%
Whole Body Radiation
60%
Neutropenia
40%
Cytokine
40%
Platelet
40%
Thrombocytopenia
40%
T Lymphocyte
40%
Cyclophosphamide
40%
Fludarabine
40%
Bone Marrow Suppression
40%
Bone Marrow Failure
20%
Acute Lymphoblastic Leukemia
20%
Neutrophil
20%
Overall Survival
20%
Metastatic Melanoma
20%
Cardiotoxicity
20%
Absolute Neutrophil Count
20%
Lymphocytopenia
20%
Febrile Neutropenia
20%
Chimeric Antigen Receptor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Neoplasm
100%
Cytokine
66%
Cyclophosphamide
66%
Neutropenia
66%
Thrombocytopenia
66%
Bone Marrow Suppression
66%
Fludarabine
66%
Malignant Neoplasm
33%
Acute Lymphoblastic Leukemia
33%
Cardiotoxicity
33%
Overall Survival
33%
Metastatic Melanoma
33%
Chimeric Antigen Receptor
33%
Febrile Neutropenia
33%
Bone Marrow Depression
33%
Lymphocytopenia
33%
Immunology and Microbiology
T Cell
100%
Lymphocyte Count
60%
Blood Level
40%
Lymphocyte
40%
Cytokine
40%
Cyclophosphamide
40%
Neutrophil
20%
Neutrophil Count
20%
Lymphocytopenia
20%
Platelet Count
20%
Platelet
20%
Overall Survival
20%
Chimeric Antigen Receptor
20%